SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001387131-21-002342
Filing Date
2021-02-16
Accepted
2021-02-12 20:00:29
Documents
1
Group Members
DAVID C. OTTDRAGSA 76 LLCO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LPVIKING GLOBAL OPPORTUNITIES LIQUID PORTFOLIO SUB-MASTER LPVIKING GLOBAL OPPORTUNITIES PORTFOLIO GP L

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 abcl-sc13ga_123120.htm SC 13G/A 237056
  Complete submission text file 0001387131-21-002342.txt   238883
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Subject) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91923 | Film No.: 21631284
SIC: 2834 Pharmaceutical Preparations